Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Has results × Breast Neoplasms × Clear all

Phase

Status

Completed 1212 Terminated 360 Active not recruiting 93 Unknown 9 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 1 Histiocytic Sarcoma 1 Dendritic Cell Sarcoma, Interdigitating 1 Dendritic Cell Sarcoma, Follicular 1 Breast Neoplasms 1

Interventions

eribulin 1 Taxes 1 Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02037529 2024-08-20

Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer

Academic and Community Cancer Research United

Phase 3 Suspended

201 enrolled 19 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡